Similar articles

• The activity of the 4 quinolone Ro 23 6240 and the cephalosporins Ro 15 8074 and Ro 19 5247 against penicillin sensitive and resistant gonococci.

  Easmon CS, Woodford N, Ison CA. Easmon CS, et al. J Antimicrob Chemother. 1987 Jun;19(6):761-5. doi: 10.1093/jac/19.6.761. J Antimicrob Chemother. 1987. PMID: 3112100
• In vitro activity of ceftriaxone, cefetamet (Ro 15-8074), ceftetrame (Ro 19-5247; T-2588), and fleroxacin (Ro 23-6240; AM-833) versus Neisseria gonorrhoeae and Haemophilus ducreyi.

  Le Saux NM, Slaney LA, Plummer FA, Ronald AR, Brunham RC. Le Saux NM, et al. Antimicrob Agents Chemother. 1987 Jul;31(7):1153-4. doi: 10.1128/AAC.31.7.1153. Antimicrob Agents Chemother. 1987. PMID: 2959199 Free PMC article.
• In vitro activity of the new quinolone RO 23-6240 (AM-833) and the new cephalosporins RO 15-8074 and RO 19-5247 (T-2525) against Mycobacterium fortuitum and Mycobacterium chelonae.

  Hohl P, Salfinger M, Kafader FM. Hohl P, et al. Eur J Clin Microbiol. 1987 Aug;6(4):487-8. doi: 10.1007/BF02013118. Eur J Clin Microbiol. 1987. PMID: 3117539 No abstract available.
• In vitro activity of Ro 15-8074, Ro 19-5247, A-56268, and roxithromycin (RU 28965) against Neisseria gonorrhoeae and Chlamydia trachomatis.

  Bowie WR, Shaw CE, Chan DG, Black WA. Bowie WR, et al. Antimicrob Agents Chemother. 1987 Mar;31(3):470-2. doi: 10.1128/AAC.31.3.470. Antimicrob Agents Chemother. 1987. PMID: 2953304 Free PMC article.
• [Revaluation of current antimicrobials. Series 22: cefteram pivoxil].

  Oizumi K, Iwai N. Oizumi K, et al. Jpn J Antibiot. 1994 Dec;47(12):1613-20. Jpn J Antibiot. 1994. PMID: 7877245 Review. Japanese. No abstract available.